Compound Detail
CHEMBL5633137
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5633137 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FAKYWDLIOSDCID-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
378.9
MW (Da)
5.03
ALogP
6
HBA
2
HBD
79.4
PSA (Ų)
0.46
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Receptor-interacting serine/threonine-protein kinase 2 CHEMBL5014 | IC50 | 8.0 | 7.405 | 10.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Receptor-interacting serine/threonine-protein kinase 2 | IC50 | = | 10.0 | nM | 8.0 | Inhibition of N-terminal polyHis-tagged human RIPK2 (8 to 310 residues) expresse... | 37598483 |
| Receptor-interacting serine/threonine-protein kinase 2 | IC50 | = | 155.0 | nM | 6.81 | Inhibition of RIPK2-mediated NF-kappaB signalling in C14-TriLAN-Gly-treated huma... | 37598483 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37598483 | 10.1016/j.ejmech.2023.115717 | Receptor-interacting serine/threonine-protein kinase 2 | 3 |
| 37598483 | 10.1016/j.ejmech.2023.115717 | Receptor-interacting serine/threonine-protein kinase 3 | 1 |
| 37598483 | 10.1016/j.ejmech.2023.115717 | Receptor-interacting serine/threonine-protein kinase 1 | 1 |
| 37598483 | 10.1016/j.ejmech.2023.115717 | Receptor-interacting serine/threonine-protein kinase 4 | 1 |
Data from ChEMBL 36 via Core Engine